Published in J Clin Oncol on October 01, 1998
Fentanyl for the treatment of tumor-related breakthrough pain. Dtsch Arztebl Int (2013) 1.81
Recent advances in the use of opioids for cancer pain. J Pain Res (2009) 0.95
Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain. Br J Cancer (2007) 0.94
A comprehensive review of rapid-onset opioids for breakthrough pain. CNS Drugs (2012) 0.93
Considerations in selecting rapid-onset opioids for the management of breakthrough pain. J Pain Res (2013) 0.92
Characterization of cancer-induced bone pain: an exploratory study. Support Care Cancer (2010) 0.85
Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis. Support Care Cancer (2004) 0.83
[Oral transmucosal fentanyl citrate for the treatment of breakthrough pain. Results of a non-interventional study (NIS)]. Schmerz (2007) 0.83
Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology. Int J Nanomedicine (2007) 0.78
Outpatient management of sickle cell pain with chronic opioid pharmacotherapy. J Natl Med Assoc (2004) 0.78
Canadian recommendations for the management of breakthrough cancer pain. Curr Oncol (2016) 0.77
Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial. Int J Clin Oncol (2014) 0.75
[Dose-finding for treatment with a transdermal fentanyl patch : Titration with oral transmucosal fentanyl citrate and morphine sulfate]. Schmerz (2016) 0.75
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature (2001) 15.44
Genome sequence of Yersinia pestis, the causative agent of plague. Nature (2001) 14.36
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
Massive gene decay in the leprosy bacillus. Nature (2001) 11.98
Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature (2000) 9.86
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol (1996) 4.07
Defining the clinically important difference in pain outcome measures. Pain (2000) 3.88
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist (2000) 3.62
A molecular link between stem cell regulation and floral patterning in Arabidopsis. Cell (2001) 3.55
A genetic framework for floral patterning. Nature (1998) 3.42
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27
The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature (2008) 3.02
Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature (2002) 2.59
Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage (1990) 2.48
Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain (1986) 2.44
The management of cancer pain. CA Cancer J Clin (1994) 2.41
Complications from regional anaesthesia for carotid endarterectomy. Br J Anaesth (2000) 2.13
An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain (1999) 2.09
The measurement of symptoms in children with cancer. J Pain Symptom Manage (2000) 1.85
Salmonella enterica serovar Typhi possesses a unique repertoire of fimbrial gene sequences. Infect Immun (2001) 1.83
Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart (2008) 1.78
Pain and its persistence in herpes zoster. Pain (1996) 1.68
Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage (1999) 1.68
Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Symptom Manage (1990) 1.52
Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol (1995) 1.47
Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates. Pain (1996) 1.46
The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain. Anesth Analg (1999) 1.45
Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain (2001) 1.43
Central pain from cerebral abscess: thalamic syndrome in AIDS patients with toxoplasmosis. Neurology (1992) 1.42
The undertreatment of pain in ambulatory AIDS patients. Pain (1997) 1.40
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain (1999) 1.39
Oral transmucosal etomidate in volunteers. Anesthesiology (1998) 1.39
Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care (1994) 1.38
Individual variability in the response to different opioids: report of five cases. Pain (1992) 1.36
Pain syndromes and etiologies in ambulatory AIDS patients. Pain (1997) 1.35
Effect on attendance at breast cancer screening of adding a self administered questionnaire to the usual invitation to breast screening in southern England. J Epidemiol Community Health (1998) 1.33
International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol (2001) 1.28
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27
An institutional commitment to pain management. J Clin Oncol (1995) 1.23
A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. J Pain Symptom Manage (2000) 1.22
Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst (1998) 1.20
Production of herpes simplex virus fluorescein labelled typing reagents. J Virol Methods (1993) 1.20
Pain management in patients with pancreatic carcinoma. Cancer (1996) 1.20
Quality of life of women with ovarian cancer. Gynecol Oncol (1995) 1.19
Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage (1990) 1.17
Responding to intractable terminal suffering. Ann Intern Med (2000) 1.16
Pain in ambulatory AIDS patients. II: Impact of pain on psychological functioning and quality of life. Pain (1996) 1.16
Headache in cerebrovascular disease. Stroke (1985) 1.14
Interventions for the prevention and management of neck/upper extremity musculoskeletal conditions: a systematic review. Occup Environ Med (2006) 1.12
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome. J Clin Oncol (1988) 1.09
Implementing national standards for cancer pain management: program model and evaluation. J Pain Symptom Manage (1996) 1.09
[Prevalence of myocardial infarction and coronary heart disease in adults aged 40-79 years in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2013) 1.06
Quality of life and survival: the role of multidimensional symptom assessment. Cancer (1998) 1.03
[Prevalence of dyslipidemia among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS 1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2013) 1.00
Opioid poorly-responsive cancer pain. Part 1: clinical considerations. J Pain Symptom Manage (2001) 1.00
I.v. infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep (1986) 1.00
Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression. Am J Transplant (2005) 0.99
Proposed classification of herpes zoster pain. Lancet (1994) 0.99
[Mental disorders in the general population : Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)]. Nervenarzt (2014) 0.98
Palliative treatment of last resort and assisted suicide. Ann Intern Med (2000) 0.98
Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol (1986) 0.98
Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. Ann Oncol (2005) 0.98
Pain, opioid use, and survival in hospitalized patients with advanced cancer. J Clin Oncol (1992) 0.97
Levels of periodontal pathogens in neonatal gastric aspirates and possible maternal sites of origin. Mol Oral Microbiol (2011) 0.96
Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther (1990) 0.96
Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate. Anesthesiology (1998) 0.95
Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology (1994) 0.95
Publication of papers on assisted suicide and terminal sedation. Ann Intern Med (2000) 0.95
Early seizures following intracerebral hemorrhage: implications for therapy. Neurology (1988) 0.95
The open window of susceptibility to infection after acute exercise in healthy young male elite athletes. Exerc Immunol Rev (2010) 0.94
Cancer pain management. Current strategy. Cancer (1993) 0.94
Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage (2000) 0.94
Characterization of breakthrough pain by hospice patients and their caregivers. J Pain Symptom Manage (1998) 0.94
Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy. Cancer (1992) 0.93
Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain. J Pain Symptom Manage (2001) 0.93
Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients. Pain (1995) 0.92
Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosis. Oncology (Williston Park) (1998) 0.92
Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study. Palliat Med (2004) 0.92
Treatment of opioid-induced constipation with oral naloxone: a pilot study. Clin Pharmacol Ther (1992) 0.92
Opioid poorly-responsive cancer pain. Part 2: basic mechanisms that could shift dose response for analgesia. J Pain Symptom Manage (2001) 0.91
Depression augments activity-related pain in women but not in men with chronic musculoskeletal conditions. Pain Res Manag (2008) 0.91
Opioid therapy for chronic nonmalignant pain: clinician's perspective. J Law Med Ethics (1996) 0.90
Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer (1995) 0.90
Ventilatory acclimatization to hypoxia is not dependent on arterial hypoxemia. J Appl Physiol (1985) (1985) 0.89
Regional myocardial blood flow and coronary vascular reserve in unanesthetized young calves exposed to a simulated altitude of 3500 m for 8--10 weeks. Circ Res (1982) 0.88
Comparative measurements of platelet size by Coulter Counter, microscopy of blood smears, and light-transmission studies. Relationship between platelet size and shape. J Lab Clin Med (1981) 0.88
Continuous intravenous infusion of opioid drugs. Med Clin North Am (1987) 0.88
Visual loss due to progressive multifocal leukoencephalopathy in a congenital immunodeficiency disorder. Arch Ophthalmol (2001) 0.87
Back pain in the cancer patient: an algorithm for evaluation and management. Neurology (1987) 0.87
Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness. J Pain Symptom Manage (2001) 0.86
Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates. J Pediatr (1999) 0.86